Bostwick D G, Qian J, Bergstralh E, Dundore P, Dugan J, Myers R P, Oesterling J E
Department of Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
J Urol. 1996 Apr;155(4):1361-7.
Capsular perforation and seminal vesicle invasion are unfavorable prognostic factors in prostate cancer. Accurate preoperative prediction of these factors would be clinically useful for planning treatment, especially in patients being considered for radiation therapy, nerve sparing radical prostatectomy and watchful waiting. However, current methods are imprecise at predicting the presence and extent of these factors. We determined which combination of commonly available preoperative variables provides the best prediction of capsular perforation and seminal vesicle invasion of patients with clinically localized prostate cancer.
We reviewed the preoperative medical records and biopsy findings from 314 patients with clinical stages T1cN0M0 to T2cN0M0 cancer who underwent radical retropubic prostatectomy and bilateral pelvic lymphadenectomy between September 1991 and June 1993. Radical prostatectomy specimens were embedded and evaluated by whole mount sections.
Capsular perforation was observed in 104 patients (33.1%) and seminal vesicle invasion was noted in 46(14.6%). Preoperative variables predictive of capsular perforation and seminal vesicle invasion on univariate analysis were serum prostate specific antigen (PSA) concentration, clinical, stage, Gleason primary and secondary patterns, Gleason score, nuclear grade, perineural invasion and percent cancer in the biopsy specimens. On multivariate analysis, independent prognostic factors for capsular perforation and seminal vesicle invasion were PSA, Gleason score and percent cancer in the biopsy specimens.
The combination of serum PSA concentration, Gleason score and percent cancer in the biopsy specimens provides the best prediction of capsular perforation and seminal vesicle invasion. Models based on this combination of factors may be clinically use to stratify patients for nonoperative treatment.
包膜穿孔和精囊侵犯是前列腺癌不良的预后因素。准确术前预测这些因素对治疗方案的制定具有临床指导意义,尤其对于考虑接受放射治疗、保留神经的根治性前列腺切除术及密切观察等待的患者。然而,目前的方法在预测这些因素的存在及程度方面并不精确。我们确定了哪些常见术前变量组合能最佳预测临床局限性前列腺癌患者的包膜穿孔和精囊侵犯情况。
我们回顾了1991年9月至1993年6月期间接受耻骨后根治性前列腺切除术及双侧盆腔淋巴结清扫术的314例临床分期为T1cN0M0至T2cN0M0癌症患者的术前病历和活检结果。根治性前列腺切除标本经包埋后进行整体切片评估。
104例患者(33.1%)观察到包膜穿孔,46例(14.6%)发现精囊侵犯。单因素分析中,术前预测包膜穿孔和精囊侵犯的变量包括血清前列腺特异性抗原(PSA)浓度、临床分期、Gleason主要和次要模式、Gleason评分、核分级、神经周围侵犯及活检标本中癌组织的百分比。多因素分析显示,包膜穿孔和精囊侵犯的独立预后因素为PSA、Gleason评分及活检标本中癌组织的百分比。
血清PSA浓度、Gleason评分及活检标本中癌组织的百分比组合能最佳预测包膜穿孔和精囊侵犯情况。基于这些因素组合的模型可能在临床上用于对患者进行非手术治疗分层。